Click on the research reports below for the latest analysis from any of our analysts.
BeneluxABI, ABLX, COFB, EXM, FUR, GLPG, GTCL, GVNV, IMMO, KPN, MITRA, QFG, SOLB, TNET, USG — 29 apr 2016Read full report BeneluxCYAD — 27 apr 2016
Celyad is a biopharmaceutical company developing cell therapies for the treatment of ischemic heart failure and cancers. Its focus is to engineer naturally occurring cells to unleash the strength within patients to fight dise ...Read full report
BeneluxBEFB, CYAD, DELB, EURN, NYR, RAND, THR, WES — 27 apr 2016
Befimmo: AGM confirms earlier statements
Celyad: Curing hearts and killing cancer
Delhaize: Confirming positive momentum
Euronav: Strong start to the year
Nyrstar: Mining disposal process and PP upgrade on track
Randstad ...Read full report
BeneluxBEFB, BCART, BPOST, DSM, EXM, IBAB, QFG, RAND, RES, TESB, UMI, WDP, WES — 26 apr 2016
Befimmo: 1Q16 results preview
Biocartis: Exclusive license of colorectal biomarkers
bpost: Preview 1Q16
DSM: 1Q16 EBITDA +19%, better than expected
EXMAR: Earnings preview
IBA: Feedback CMD on ProteusOne in Nice
Quest f ...Read full report
BeneluxBINCK, CRBN, DSM, EURN, FUR, INTO, MOBB, SOLB, TESB, UCB, UMI — 25 apr 2016Read full report
BeneluxAGS, ARCAD, COFB, CRBN, DELB, GLPG, GVNV, KPN, MELE, MOBB, RAND — 22 apr 2016Read full report
RESEARCH SIGN IN
Need to register for an account?
Need help accessing our research?